(19)
(11) EP 4 447 942 A1

(12)

(43) Date of publication:
23.10.2024 Bulletin 2024/43

(21) Application number: 22843139.1

(22) Date of filing: 19.12.2022
(51) International Patent Classification (IPC): 
A61K 9/51(2006.01)
C12N 15/861(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/5184; C12N 15/86; C12N 2750/14143; C12N 15/102; C12N 2750/14145; C12N 2810/40; C12N 2310/20; C12N 9/22; A61K 48/0041; A61K 48/005; A61K 38/00; C12N 15/1137; C12Y 114/13039; A61P 9/10; A61P 9/00
(86) International application number:
PCT/EP2022/086634
(87) International publication number:
WO 2023/111351 (22.06.2023 Gazette 2023/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 17.12.2021 EP 21215501

(71) Applicant: Kupatt, Christian
81371 München (DE)

(72) Inventors:
  • BOZOGLU, Tarik
    80997 Munich (DE)
  • ZIEGLER, Tilman
    80796 Munich (DE)
  • KUPATT, Christian
    81371 Munich (DE)

(74) Representative: Grund, Martin 
Grund Intellectual Property Group Patentanwälte und Solicitor PartG mbB Steinsdorfstraße 2
80538 München
80538 München (DE)

   


(54) AAV VECTORS FOR GENE THERAPY IN ENDOTHELIAL CELLS